What is it about?
I consider Bob's influence on the science of Drug Regulation and make some suggestions as to how we could make clinical trials even more efficient.
Featured Image
Why is it important?
Not dichomotising continuous measures and using baselines as covariates are two simple steps that could improve dramatically the efficiency of clinical trials.
Read the Original
This page is a summary of: Being Efficient About Efficacy Estimation, Statistics in Biopharmaceutical Research, August 2013, Taylor & Francis,
DOI: 10.1080/19466315.2012.754726.
You can read the full text:
Resources
Contributors
The following have contributed to this page
